🇺🇸 FDA

Drug profile · INN

montelukast sodium

MONTELUKAST SODIUM

approved
US status
approved
Patents linked
1
News articles
0

Quick answer

montelukast sodium (MONTELUKAST SODIUM) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN montelukast sodium
Brand MONTELUKAST SODIUM
Route ORAL
Formulation TABLET

Related patents

Search patents →

Frequently asked questions

What is montelukast sodium?

montelukast sodium (MONTELUKAST SODIUM) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for montelukast sodium?

MONTELUKAST SODIUM is a marketed brand name for montelukast sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of montelukast sodium?

montelukast sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.